Cargando…

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis

High levels of circulating triglycerides (TGs), or hypertriglyceridemia, are key components of metabolic diseases, such as type 2 diabetes, metabolic syndrome, and CVD. As TGs are carried by lipoproteins in plasma, hypertriglyceridemia can result from overproduction or lack of clearance of TG-rich l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitacre, Brynne E., Howles, Philip, Street, Scott, Morris, Jamie, Swertfeger, Debi, Davidson, W. Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953696/ https://www.ncbi.nlm.nih.gov/pubmed/34863862 http://dx.doi.org/10.1016/j.jlr.2021.100157

Ejemplares similares

Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
por: Takahashi, Sadao
Publicado: (2017)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
por: Wieczorek, Ewa, et al.
Publicado: (2021)

Genetic association of LPL rs1121923 and rs258 with plasma TG and VLDL levels
por: Al-Bustan, Suzanne A., et al.
Publicado: (2019)

Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects
por: Di Filippo, Mathilde, et al.
Publicado: (2014)

Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
por: Qiao, Liping, et al.
Publicado: (2008)

Correction: Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects
Publicado: (2014)

VLDL Hydrolysis by Hepatic Lipase Regulates PPARδ Transcriptional Responses
por: Brown, Jonathan D., et al.
Publicado: (2011)

PMON31 IL-4 Serum Levels Correlate with Triglycerides and VLDL in African American males
por: Johnson, Abraham, et al.
Publicado: (2022)

Pregnancy is accompanied by larger high density lipoprotein particles and compositionally distinct subspecies
por: Melchior, John T., et al.
Publicado: (2021)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Gene-environment interactions due to quantile-specific heritability of triglyceride and VLDL concentrations
por: Williams, Paul T.
Publicado: (2020)

Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
por: Mendivil, Carlos O., et al.
Publicado: (2013)

Lipoprotein size is a main determinant for the rate of hydrolysis by exogenous LPL in human plasma
por: Kovrov, Oleg, et al.
Publicado: (2021)

Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
por: Li, Yan-hong, et al.
Publicado: (2014)

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2014)

Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment
por: Samson, Clarissa E., et al.
Publicado: (2012)

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
por: Ooi, Esther M.M., et al.
Publicado: (2008)

The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
por: Dlugosz, Paula, et al.
Publicado: (2018)

Apolipoprotein E-containing HDL decreases caspase-dependent apoptosis of memory regulatory T lymphocytes
por: Atehortua, Laura, et al.
Publicado: (2023)

Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2015)

Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

The Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat
por: Kabagambe, Edmond K., et al.
Publicado: (2012)

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes
por: Carlier, Aurélie, et al.
Publicado: (2020)

ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition
por: Chen, Yan Q., et al.
Publicado: (2021)

LncRP11-675F6.3 responds to rapamycin treatment and reduces triglyceride accumulation via interacting with HK1 in hepatocytes by regulating autophagy and VLDL-related proteins: LncRNA with HK1 regulates triglycerides, autophagy and VLDL
por: Wang, Lingling, et al.
Publicado: (2023)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
por: Millar, John S., et al.
Publicado: (2017)

Amelioration of Hypertriglyceridemia with Hypo-Alpha-Cholesterolemia in LPL Deficient Mice by Hematopoietic Cell-Derived LPL
por: Ding, Yinyuan, et al.
Publicado: (2011)

MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice
por: Ye, Qiong, et al.
Publicado: (2018)

Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides
por: Rayner, Katey J., et al.
Publicado: (2011)

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)

VLDL-associated mutagenic activity.
por: Gomes, M. I., et al.
Publicado: (1982)

Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases
por: Wu, Yun Qin, et al.
Publicado: (2021)

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
por: Lin, Huige, et al.
Publicado: (2022)

Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study
por: Ariza, María-José, et al.
Publicado: (2010)

GPIHBP1 and ANGPTL4 Utilize Protein Disorder to Orchestrate Order in Plasma Triglyceride Metabolism and Regulate Compartmentalization of LPL Activity
por: Kristensen, Kristian Kølby, et al.
Publicado: (2021)

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif
por: Balasubramaniam, Deepa, et al.
Publicado: (2022)

Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome
por: Broedl, Uli C, et al.
Publicado: (2006)

THE EFFECT OF TEMPERATURE ON THE RATE OF HYDROLYSIS OF TRIGLYCERIDES BY PANCREATIC LIPASE
por: Schwartz, Boris
Publicado: (1943)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rqcajkmm768lv0u50fuqt7msdb